Search

everythinglearnresearchcommunity

for

Search:↓

Long-term Finasteride treatment reduces depression better than short-term treatment in rats.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Topical minoxidil improved hair loss in a patient when used consistently.

Oral minoxidil is effective for various hair loss types and may improve male sexual function, but aspirin can reduce its effectiveness.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

The document suggests that drugs for prostate issues might cause lasting sexual, mental, and physical health problems due to blood vessel damage in the penis.

5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.

Man experienced post-finasteride syndrome symptoms after using finasteride and dutasteride for hair loss.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

More research needed to confirm finasteride as standard treatment for FFA.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

The document discusses new insights into how hormones affect male sexual health and related conditions.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.